Search Browse Earnings

CERO THERAPEUTICS HOLDINGS, INC.

OTC:CEROOTC:CEROW

Biological Products, (No Diagnostic Substances)·SOUTH SAN FRANCISCO, CA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

CERO THERAPEUTICS HOLDINGS, INC. — SlamSEC

Revenue

—

Adj. EBITDA

—

Net Income

-$7.3M

FY 2024

EPS (Diluted)

-$1248.64

FY 2024

Stock Price

—

52W Range

—

P/E Ratio

—

Market Cap

—

Cash

$475,870

FY 2023

Total Debt

—

Net Cash

$475,870

Enterprise Value

—

Debt / EBITDA

—

EV / EBITDA

—

Employees

—

CEO

Ehrlich Christopher B

CFO

Kucharchuk Andrew Albert